{
  "chapter": "Malignant Tumors of Liver",
  "questions": [
    {
      "q_no": 1,
      "question": "Patients with hepatocellular carcinoma are least likely to present with",
      "options": {
        "A": "Abdominal pain",
        "B": "Jaundice",
        "C": "Weight loss",
        "D": "Palpable mass"
      },
      "correct_answer": "",
      "explanation": "",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Malignant Tumors of Liver"
    },
    {
      "q_no": 2,
      "question": "Which of the following is not a risk factor for hepatocellular carcinoma?",
      "options": {
        "A": "Oral contraceptive pills use",
        "B": "Non-alcoholic steatohepatitis",
        "C": "Hepatitis B",
        "D": "Primary biliary cirrhosis"
      },
      "correct_answer": "",
      "explanation": "Oral contraceptive use is not an independent risk factor for hepatocellular carcinoma. It is a riskfactor for developing hepatic adenoma.721Although hepatocellular adenoma can undergo malignant transformation, the true risk is low(10%).Major risk factors for hepatocellular carcinoma:• Infection:••Hepatitis B• Hepatitis C• Toxins/drugs:•• Alcoholic cirrhosis• Aflatoxins• Anabolic steroids•Genetic:•Hemochromatosis⚫α1-Antitrypsin deficiency• Immunological:• Autoimmune chronic active hepatitis• Primary biliary cirrhosis• Others:• Obesity• Nonalcoholic steatohepatitis• Cirrhosis (other causes and idiopathic).",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Malignant Tumors of Liver"
    },
    {
      "q_no": 3,
      "question": "Which of the following can be seen with HCC?",
      "options": {
        "A": "Hypercalcemia",
        "B": "Hyperglycemia",
        "C": "Hyponatremia",
        "D": "Hyperkalemia"
      },
      "correct_answer": "A",
      "explanation": "Paraneoplastic syndrome due to hepatocellular carcinoma can manifest as:• Hypercalcemia⚫ Hypoglycemia• ErythrocytosisHypercalcemia in patients with HCC is associated with increased renal reabsorption ofcalcium and increased bone resorption by parathyroid hormone-related protein (PTHrP)generated by HCC.Less than 1% of cases of HCC manifest with a paraneoplastic syndrome.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Malignant Tumors of Liver"
    },
    {
      "q_no": 4,
      "question": "A 57-year-old man presented with persistent upper abdominal pain and weight loss.Ultrasound revealed a lesion in the right lobe of the liver and contrast-enhanced CT wassuggestive of hepatocellular carcinoma. Which of the following tumor markers can beelevated in this patient?",
      "options": {
        "A": "1 and 5715",
        "B": "1, 2, 4 and 5",
        "C": "3 and 5",
        "D": "2, 3 and 4"
      },
      "correct_answer": "B",
      "explanation": "Alpha-2-macroglobulin is not a tumor marker of HCC.722Tumor markers of HCC are:•●Alpha-fetoprotein (AFP)• Normal (&lt;20 ng/mL),•Elevated (21-400 ng/mL), and• Diagnostic for HCC (&gt;400 ng/mL).•Protein Induced by Vitamin K Absence or Antagonist - II (PIVKA-II) also calleddes-gamma-carboxy prothrombin (DCP)•Glypican 3.• Neurotensin (in fibrolamellar type)",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Malignant Tumors of Liver"
    },
    {
      "q_no": 5,
      "question": "A 43-year-old man presented to the hospital with complaints of abdominal pain, ascites, andweight loss for 6 months. Investigations revealed a thrombus in the portal vein along withinvasion from nearby tumor growth. Which of the following conditions can cause this?",
      "options": {
        "A": "Hepatic adenoma",
        "B": "Hepatocellular carcinoma",
        "C": "Focal nodular hyperplasia",
        "D": "Cavernous hemangioma"
      },
      "correct_answer": "B",
      "explanation": "In the above clinical scenario, the patient has a secondary Budd-Chiari syndrome due to portalvein obstruction by a neighboring invasive lesion. Hepatocellular carcinoma (HCC) has thehighest tendency to invade the portal vein.Budd-Chiari syndrome (BCS) is an uncommon congestive hepatopathy characterized by theobstruction of hepatic venous outflow.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Malignant Tumors of Liver"
    },
    {
      "q_no": 6,
      "question": "Which of the following is not true regarding the fibrolamellar variant of HCC?",
      "options": {
        "A": "Commonly associated with cirrhosis",
        "B": "Recurrences are seen despite better prognosis",
        "C": "Occur under the age of 35 years",
        "D": "Not commonly associated with chronic hepatitis B infection"
      },
      "correct_answer": "A",
      "explanation": "Fibrolamellar variant of HCC is not commonly associated with liver cirrhosis.Fibrolamellar carcinoma is a distinctive variant (&lt;5%) of HCC. They occur under the age of 35years, without any gender predilection or identifiable predisposing conditions.It usually presents as a single large, hard 'scirrhous' tumor. The tumor is well-demarcated,encapsulated, and may have a central fibrotic area. Histology shows large polygonal cellsembedded in a fibrous stroma forming lamellar structures.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Malignant Tumors of Liver"
    },
    {
      "q_no": 7,
      "question": "A 25-year-old male patient is found to have a well-circumscribed mass in his liver and issuspected to have fibrolamellar HCC. Which of the following tumor markers will be elevatedin his condition?",
      "options": {
        "A": "AFP",
        "B": "Neurotensin",
        "C": "ALP",
        "D": "Glypican-3"
      },
      "correct_answer": "B",
      "explanation": "Neurotensin is the tumor marker of fibrolamellar hepatocellular carcinoma (HCC).Neurotensin is a mitogen which induces cell proliferation in fibrolamellar hepatocellularcarcinoma. There is increased serum unsaturated vitamin B12 binding capacity seen infibrolamellar HCC which can also aid in diagnosis.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Malignant Tumors of Liver"
    },
    {
      "q_no": 8,
      "question": "716Which of the following statements is not true about alpha-fetoprotein?",
      "options": {
        "A": "AFP level does not return back to normal after hepatic resection",
        "B": "Levels of &gt;400 ng/mL with typical radiological findings is suggestive of HCC",
        "C": "AFP level can be raised in benign conditions",
        "D": "Fibrolamellar HCC has normal levels"
      },
      "correct_answer": "A",
      "explanation": "723Alpha-fetoprotein (AFP) level returns to normal after resection.Alpha-fetoprotein is a glycoprotein that is produced in early fetal life by the liver. It is alsoproduced by a variety of tumors, such as:• Hepatocellular carcinoma• Hepatoblastoma•• Non-seminomatous germ cell tumors of the ovary and testis (e.g., yolk sac and embryonalcarcinoma).AFP is also elevated during the following conditions:••• Pregnancy and in benign liver disease (e.g., viral hepatitis, cirrhosis)Gastrointestinal tract tumors• Along with carcinoembryonic antigen in ataxia-telangiectasiaLimitations of AFP include low sensitivity and specificity. It is not specific to HCC and can occurwith intrahepatic cholangiocarcinoma and colorectal metastases.Levels &gt;400 ng/mL with typical radiological findings are suggestive of HCC. Alpha-fetoprotein(AFP) is not elevated in fibrolamellar HCC.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Malignant Tumors of Liver"
    },
    {
      "q_no": 9,
      "question": "AFP is used as a tumor marker in which of the following cancers?",
      "options": {
        "A": "2 and 3",
        "B": "3, 4 and 5",
        "C": "1 and 3",
        "D": "1, 2 and 5"
      },
      "correct_answer": "D",
      "explanation": "Alpha-fetoprotein (AFP) is not a tumor marker used to detect cholangiocarcinoma or fibrolamellarHCC.It is produced by a variety of tumors such as:• Hepatocellular carcinoma (HCC)• Hepatoblastoma• Non-seminomatous germ cell tumors of the ovary and testis (e.g., yolk sac and embryonalcarcinoma).",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Malignant Tumors of Liver"
    },
    {
      "q_no": 10,
      "question": "Which of the following are modalities of treatment in patients with hepatocellular carcinoma?",
      "options": {
        "A": "1, 2, 4",
        "B": "1 and 5",
        "C": "1,3,5",
        "D": "1, 2, 3, 4 and 5"
      },
      "correct_answer": "D",
      "explanation": "All of the given modalities can be used for the treatment of HCC.Treatment options for hepatocellular carcinoma (HCC):•Surgical•Resection (the mainstay of treatment)•Orthotopic liver transplantation•• Ablative•Percutaneous ethanol injection (PEI) (less frequently used nowadays)•• Thermal ablation (cryotherapy, radiofrequency ablation, microwave, Nd-YAG laser)724• Transarterial.• Embolization• Chemoembolization• Radiotherapy•••Combination of transarterial and ablative: external beam radiationSystemicChemotherapy• Hormonal••Immunotherapy",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Malignant Tumors of Liver"
    },
    {
      "q_no": 11,
      "question": "A 50-year-old man has been diagnosed with localized hepatocellular carcinoma. He falls intochild-pugh class A and his future liver remnant is 22% of the total liver volume. Which of thefollowing will decrease the tumor burden and improve his hepatic functional reserve?",
      "options": {
        "A": "Resection followed by chemotherapy",
        "B": "Preoperative portal vein embolization followed by resection",
        "C": "Radiotherapy, followed by chemotherapy",
        "D": "Intralesional ethanol"
      },
      "correct_answer": "B",
      "explanation": "The patient should ideally be treated by preoperative portal vein embolization to improve hepaticfunctional reserve, followed by resection which will decrease the tumor burden.•Portal venous embolization on the side of the tumor will lead to compensatory hypertrophy of theunaffected liver lobe. This improves the volume and function of the future liver remnant (FLR).Localized hepatocellular carcinomaChild-Pugh class A: Patients with child-pugh class A should undergo resection of the tumor.• Those with low FLR (&lt;30%) should ideally be treated by preoperative portal vein embolizationfollowed by resection. Preoperative embolization helps in improving the FLR volume functionprior to resection.•Those with adequate FLR (&gt;30-40%) can usually tolerate resection alone.Child-Pugh class B/C or portal hypertension: Patients with early-stage HCC and child-Pugh classB/C or portal hypertension should be considered for transplantation.Advanced hepatocellular carcinomaPatients with advanced hepatocellular carcinoma are treated with palliative intent. Following arethe management options:●•• Drug therapy - Sorafenib/ Sunitinib/ Regorafenib• Transarterial chemoembolisation (TACE) and transarterial radioembolisation (TARE) offer thebest results in multifocal diseaseRadiofrequency ablation, microwave ablation, high-frequency ultrasound therapy are alternativeoptions• Patients with extreme deterioration of performance status and liver function should be offeredsupportive treatment only.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Malignant Tumors of Liver"
    },
    {
      "q_no": 12,
      "question": "717Which of the following parameters is not considered in OKUDA staging?",
      "options": {
        "A": "Bilirubin",
        "B": "Tumor size",
        "C": "Ascites",
        "D": "AFP"
      },
      "correct_answer": "D",
      "explanation": "725OKUDA staging includes assessment of all the above factors except alpha-fetoprotein (AFP).The OKUDA staging system distinguishes patients with poor prognosis from those with morepotential for long-term survival. The OKUDA staging system is an older system.OKUDA staging system for hepatocellular carcinoma (HCC):Stage I: o pointsStage II: 1-2 pointsStage III: 3-4 pointsClinical parametCut-off valuPointerSSerum bilirubin<3>301Serum albumin>3<301Tumor sizeAscites<50%>50% 01AbsentPres 01ent",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Malignant Tumors of Liver"
    },
    {
      "q_no": 13,
      "question": "Which of the following scoring systems will you not use to assess oncological outcomes ofpatients with hepatocellular carcinoma?",
      "options": {
        "A": "MELD",
        "B": "BCLC",
        "C": "CLIP",
        "D": "OKUDA"
      },
      "correct_answer": "A",
      "explanation": "MELD (model for end-stage liver disease) score is not used to assess the oncological outcome ofpatients with hepatocellular carcinoma. MELD is used to predict the severity of end-stage chronicliver disease.Barcelona Clinic Liver Cancer staging system (BCLC) is the most commonly used scoring systemfor staging and management of HCC.The staging or management of HCC is done by the following:1. Barcelona Clinic Liver Cancer staging system (BCLC)• Tumor score (TNM).• Child-Pugh score• Performance score (Barcelona clinic score)2. Cancer of the Liver Italian Program (CLIP)• Tumor size•Child-Pugh score• AFP• Portal vein thrombosis3. OKUDA staging• Bilirubin• Ascites726• Tumor size• Albumin4. Chinese University Prognostic Index (CUPI)Note: MELD can be used in prioritizing HCC patients in need of liver transplants.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Malignant Tumors of Liver"
    },
    {
      "q_no": 14,
      "question": "Which of the following is true regarding LI-RADS scoring?LI-RADS 2 has an intermediate probability of malignancyb) Treatment for hepatocellular carcinoma can be initiated in LI-RADS 5 without biopsyc) LI-RADS 3 is an indication for immediate liver biopsyd) LI-RADS 4 is definitive of hepatocellular carcinomaQuestion 15:A 70-year-old retiree was employed for two decades in a plastic industry, where he wasexposed to vinyl chloride. He is at an increased risk of developing which of the followingtumors?",
      "options": {
        "A": "Hepatocellular carcinoma",
        "B": "Angiosarcoma of liver",
        "C": "Clear cell HCC",
        "D": "Intrahepatic cholangiocarcinoma718"
      },
      "correct_answer": "B",
      "explanation": "LI-RADS 5 indicates a definitive probability(~100%) of hepatocellular carcinoma. Thereforetreatment can be initiated as early as possible without waiting for a biopsy.•Routine surveillance should be continued for LI-RADS 1, 2. Additional imaging may be requiredfor LI-RADS 2 based on individual risk.• LI-RADS 3 should be evaluated by serial imaging every 3-6 months.• Evaluation with a biopsy should be done in LI-RADS 4.• Since LI-RADS 5 indicates a definitive probability of hepatocellular carcinoma, treatment can beinitiated as early as possible without waiting for a biopsy.Liver Imaging Reporting andData Systems (LI-RADS) categoriesCategoryLI-RADS 1LI-RADS 2LI-RADS 3AssessmentDefinitely benignProbably benignIntermediate probability ofmalignancyLI-RADS 4Probably HCCLI-RADS 5Definitely HCC",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Malignant Tumors of Liver"
    },
    {
      "q_no": 16,
      "question": "An infant is brought to the hospital by his parents with complaints of poor feeding andabdominal distension. On evaluation, a mass is detected in the liver which is later diagnosedto be a hepatoblastoma. Which of the following is false regarding this condition?",
      "options": {
        "A": "It is associated with familial adenomatous polyposis",
        "B": "Most cases occur before the age of 3 years",
        "C": "Treatment is surgical resection followed by chemotherapy",
        "D": "Prognosis is extremely poor for pulmonary metastasis"
      },
      "correct_answer": "D",
      "explanation": "In hepatoblastoma, 85% of patients with pulmonary metastases can be successfully treated withresection of the hepatic tumor and chemotherapy or resection of the pulmonary metastases.Hepatoblastoma is the most common primary hepatic tumor of childhood. The median age atpresentation is 18 months, and almost all cases occur before 3 years of age. It has been associatedwith familial adenomatous polyposis (FAP) syndrome.This tumor generally manifests as an asymptomatic mass. Mild anemia and thrombocytosis arecommonly found at presentation.Serum alpha-fetoprotein (AFP) levels are elevated in the majority of patients and can serve as auseful marker for therapeutic response.Treatment includes chemotherapy that can help downstage tumors such that they are amenable toresection. In patients without metastatic disease or the anaplastic variant, long-term survival ratesof 60% to 70% can be expected with complete resection.Staging of pediatric liver tumors:StageStage IStage IIStage IIIStage IVFeatureNo metastases Tumor completely resectedNo metastasesTumor grosslyresected with microscopic residual disease, or tumor rupture/spill at the time of surgeryNo distant metastasesTumorunresectable or resected withgross residual tumor, or positive lymph nodesDistant metastases regardlessof the extent of liver involvement",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Malignant Tumors of Liver"
    },
    {
      "q_no": 17,
      "question": "A woman was diagnosed to have metastatic liver adenocarcinoma with CK 7 (-), CK20 (+), andCDX-1 (+) IHC markers. Which of the following is the most likely primary site of origin forthis metastasis?",
      "options": {
        "A": "Colon carcinoma",
        "B": "Breast Carcinoma",
        "C": "Pancreatic carcinoma.",
        "D": "Ovarian carcinoma"
      },
      "correct_answer": "A",
      "explanation": "Colorectal carcinoma is the most likely primary tumor for the given metastases. Among the givenoptions, cytokeratin 7 is negative only in colon carcinoma.728The most common site of distant metastasis of colorectal cancer is the liver. These metastasesarise from hematogenous spread via the portal venous system. The lung is the next most commonsite for metastasis.Cytokeratin profiles of various primary tumors:CK 7 positiveCK20 positive CholangiocarcinomaOvarianmucinous carcinomaCK 7positiveCK 20 negativCK 7negativeCK 20positiveCK 7 negativeCK 20 negativeBreast carcinomaOvarian serous adenocarcinomaThyroidcarcinomaPancreatic adenocarcinomaLung carcinomaColorectal adenocarcinomaMerkel cell carcinomaHepatocellular carcinomaRenal cell carcinoma Prostatic adenocarcinomaSquamous cel1 carcinoma",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Malignant Tumors of Liver"
    },
    {
      "q_no": 18,
      "question": "In patients with colorectal carcinoma, which of the following is not a bad prognostic factor?",
      "options": {
        "A": "Synchronous lesions",
        "B": "Multiple tumors",
        "C": "CEA level of &gt;200 ng/mL",
        "D": "Metachronous lesions"
      },
      "correct_answer": "D",
      "explanation": "Metachronous lesions are not associated with a bad prognosis in case of liver metastasis fromcolon carcinoma.A metachronous cancer is defined as secondary cancer occurring more than 6 months after theindex cancer.Synchronous cancer is defined as two or more neoplasms identified simultaneously in the samepatient, or a second tumor identified within six months after the initial diagnosis.Predictors of poor outcome in colorectal carcinoma with liver metastasis:•⚫ Lymph-node-positive primary• Disease-free interval &lt;12 months•More than one tumor.• Tumor size &gt;5 cm•Serum carcinoembryonic antigen (CEA) level &gt;200 ng/mL",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Malignant Tumors of Liver"
    },
    {
      "q_no": 19,
      "question": "Patients with which of the following conditions are not suitable for liver transplantation?",
      "options": {
        "A": "Cirrhosis",
        "B": "Primary biliary cirrhosis",
        "C": "Cholangiocarcinoma719",
        "D": "Fulminant hepatitis"
      },
      "correct_answer": "",
      "explanation": "Cholangiocarcinoma is not an indication for a liver transplant.Orthotopic liver transplantation (OLT) for patients with cholangiocarcinoma had very poor resultsand this treatment strategy has largely been abandoned.729",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Malignant Tumors of Liver"
    },
    {
      "q_no": 20,
      "question": "What is the most common indication for liver transplant in children?",
      "options": {
        "A": "Biliary atresia",
        "B": "Indian childhood cirrhosis",
        "C": "Primary sclerosing cholangitis",
        "D": "Inborn errors of metabolism"
      },
      "correct_answer": "A",
      "explanation": "The most common indication for liver transplant in children is biliary atresia.In biliary atresia, the extrahepatic bile ducts are occluded, causing obstructive jaundice(conjugated hyper-bilirubinemia) and progressive liver fibrosis in early infancy. Livertransplantation is required if not diagnosed and managed early.(option B) Indian childhood cirrhosis (ICC) is a progressive liver failure in young children,associated with marked hepatic copper overload (in excess of 800 µg/g dry weight). Unlike Wilsondisease, ICC is associated with normal or elevated ceruloplasmin levels, indicating a defect late inthe copper excretory pathway.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Malignant Tumors of Liver"
    },
    {
      "q_no": 21,
      "question": "A 5-year-old child with Wilson's disease is being considered for liver transplantation. Whichof the following is not a parameter in the selection criteria for transplantation?",
      "options": {
        "A": "Age &lt;10years",
        "B": "PT &gt;100 S",
        "C": "Bilirubin &gt;300 μmol/L",
        "D": "Jaundice less than 7 days before development of encephalopathy"
      },
      "correct_answer": "D",
      "explanation": "A 5-year-old child with Wilson's disease is a case of non-paracetamol-induced acute liver failureand jaundice for more than 7 days before the development of encephalopathy is one of theparameters in the King's College criteria for liver transplantation.It includes the following parameters:Non-paracetamol-induced acute liver failure:•• PT &gt;100 s (INR &gt;6.5)or/and• Any three of the following:•Age &lt;10 years or &gt;40 years•••Etiology non-A, non-B hepatitis, or idiosyncratic drug reactionJaundice more than 7 days before the development of encephalopathy i.e., not hyperacutePT &gt;50 s (INR &gt; 3.5)• Bilirubin &gt; 18 mg/dl (300 μmol/L)Paracetamol-induced acute liver failure:• pH &lt;7.30 (irrespective of the grade of encephalopathy)or/and• All three of the following:•• Prothrombin time &gt;100 s (INR &gt;6.5)• Serum creatinine &gt;3.4 mg/dl (300 μmol/L)• Grade 3 or 4 hepatic encephalopathy",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Malignant Tumors of Liver"
    },
    {
      "q_no": 22,
      "question": "Auxiliary orthotopic liver transplantation is indicated in which of the following conditions?",
      "options": {
        "A": "Drug induced hepatic failure",
        "B": "As standby procedure till a suitable donor is found",
        "C": "Acute fulminant liver failure that is irreversible",
        "D": "Metabolic liver disease"
      },
      "correct_answer": "D",
      "explanation": "730Auxiliary orthotopic liver transplantation (A-OLTX) is indicated in non-cirrhotic metabolic liverdisease.Auxiliary partial orthotopic liver transplantation is a technique where part of the diseased nativeliver is removed and replaced with a part of the healthy donor liver. This is done so the retainednative liver can regenerate.In selective cases of acute liver failure, auxiliary partial orthotopic liver transplantation couldprovide a chance for native liver regeneration and immunosuppression-free life.Auxillary orthotopic liver transplant is indicated for the following:•• Patients aged &lt;40 years• Reversible fulminant hepatic failure (auxiliary liver transplantation cannot be done in cases ofirreversible liver failure)• Non-cirrhotic metabolic liver disease•No hemodynamic instability• Hyperacute (not in other cases) Liver failure with Acetaminophen overdose.Total orthotopic liver transpl Auxiliary orthotopic liver traantation (OLTX)The entire liver is transplantedIndications: Fulminant hepatic failure (FHF)Liver cirrhosisPrimary biliary cirrhosisLife-long immunosuppression is required.nsplantation (A-OLTX)Only a portion of the liver is transplantedIndications:Crigler-Najjar syndrome type IHomozygous familial hypercholesterolemiaGalactosemiaHereditary tyrosinemiaNeimann-Pick's diseaseImmunosuppression is required until the native liver regenerates731",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Malignant Tumors of Liver"
    }
  ]
}